Indication Expansion: Opportunities for successful lifecycle management

Due to shrinking pipelines and rising financial pressures on pharmaceutical companies, indication expansion is an increasingly attractive strategy to expand patient potential and extend market exclusivity.

Indication Expansion is a new report that provides in-depth case studies analyzing successful recent indication expansions and emerging trends. This report will enable you to avoid potential pitfalls whilst gaining a comprehensive review of how to delay generic competition and boost revenue growth. Use the case studies in this report to identify best practice examples of indication expansion strategies and ensure that you can implement these into your current processes to maximize the lifecycle of your products.

Read more...

• Pharmaceutical Company Outlook (06/04/2010)
• Company Outlook (15/01/2010)
• The global generics industry (15/01/2010)

• Optimizing Partnerships with Contract Organizations (12/05/2008)

---